US 10525046
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted A61KA61K31/194A61K31/4468
Quick answer
US patent 10525046 (Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases) held by ACADIA Pharmaceuticals Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/194, A61K31/4468, A61K45/06, A61K9/20